Arriving at a firm diagnosis of neurosarcoidosis continues to pose serious problems, particularly when evidence of granulomatous disease outside the nervous system is lacking. The commonest mode of presentation of neurosarcoidosis is with cranial nerve palsies. Two cases of presumed neurosarcoidosis with cranial nerve palsies showed clear evidence of focal meningeal disease on gadolinium-DTPA enhanced MRI brain scans. Although not specific for sarcoidosis, this technique may be very useful in aiding the diagnosis in suspected cases.
Sarcoidosis is a disseminated disease of unknown aetiology characterised by non-caseating granulomatous infiltration. Neurological symptoms occur in about 5% of patients known to have the disease'2 and in up to 14% of patients at necropsy.' The commonest mode of presentation of neurosarcoidosis is with cranial nerve palsies.' Although facial nerve involvement, in particular, is frequently encountered, the pathophysiology of these lesions is poorly understood, probably because they are associated with a good prognosis.
Major diagnostic difficulties can arise, particularly in patients with no evidence of granulomatous disease outside the nervous system, because of problems in obtaining suitable tissue for histological examination. Diffuse meningeal infiltration particularly in the skull base region is (fig 2b, c) . Unenhanced Ti weighted images were not obtained as a bright sequence from the meninges would indicate a fairly acute bleed which was clinically highly unlikely.
At the age of 67 she developed epilepsy with eight attacks of right sided jerking followed by loss of consciousness for up to 20 minutes. These attacks stopped after treatment with phenytoin was started. The EEG was unremarkable. The Mantoux test was negative at 1:10,000 dilution, Kveim test was negative. No repeat CSF examination was carried out.
This woman had histologically proven noncaseating granulomatous disease of the female genital tract and of a subcutaneous buttock mass. Sarcoidosis affecting the uterus is well recognised but in fact few proven cases have been reported.' In addition she had evidence of neurological involvement, having had an episode of cranial nerve palsies and epilepsy, the latter being reported in up to 35% of cases of granulomatous meningitis.6 on the right side maximal in the region of the tentorium cerebelli (fig 3a, b, c) . T2 weighted sequences using the same sequences as before showed no abnormality in the brain stem or adjacent CSF (figs 3d, e).
This patient presented with two episodes of cranial nerve palsies without any clinical evidence of systemic disease outside the central nervous system. The illness was felt to be due to sarcoidosis although tuberculosis was obviously an important differential diagnosis. The patient was again treated with oral steroids, initially dexamethasone (16 mg/day for three weeks) and subsequently put on to a reducing regime of prednisolone over a six month period. He was also treated with isoniazid (600 mg/day for six months) as a single agent as prophylaxis against activating any previous tuberculosis. There was a gradual but steady improvement over a three month period, during which all his cranial nerve palsies resolved.
Discussion
Both these cases presented with multiple lower cranial nerve palsies. In the first case, the patient was known to have non-caseating granulomatous tissue affecting other organs. In the second case, the evidence that the meningeal disease was due to sarcoidosis was based on the overall clinical picture and response to steroid treatment, combined with the gallium scan, the lymphocytic CSF and the lack of any evidence over many years of follow up of other major causes of meningeal disease such as carcinoma and tuberculosis.
In sarcoidosis of the central nervous system, leptomeningeal disease is the commonest pattern of involvement seen, and may be localised or widespread, resulting in focal or dis- There are few reports of the demonstration of meningeal sarcoid infiltration with MRI. Greco and Steiner in 198716 reported high signal intensity of the basal meninges in one of four patients with neurosarcoidosis but Gd-DTPA was not given. Normal meninges may occasionally show faint enhancement on administration of Gd-DTPA, but abnormally brightly enhancing meninges usually indicate meningeal disease in conditions including inflammatory and malignant infiltration. [17] [18] [19] As in CT scanning the appearances are non-specific and may be due to a wide range of pathology. In both these patients no significant meningeal abnormality was noted on unenhanced MRI scans, but the meningeal enhancement seen in both patients was of very high signal intensity, strictly unilateral and on the same side as the cranial nerve palsies.
Gadolinium-DTPA is a paramagnetic contrast agent used in MRI which functions by altering local magnetic environments to change signal intensity in tissues where it accumulates. Like radiographic contrast agents, it uniformly distributes throughout the extracellular space and does not cross intact cell membranes or the intact blood-brain barrier to any extent. Administration of Gd-DTPA therefore highlights damaged or altered tissue in a nonspecific manner, similar to radiographic contrast administered in CT scanning.
In one of these patients CT scan and unenhanced MRI scan failed to demonstrate significant intracranial pathology. The sensitivity of MRI for detection of intracranial disease is superior to that of CT with a similar specificity. This is further increased by administration of Gd-DTPA. Gd-DTPA enhanced MRI should be performed in patients with suspected neurosarcoidosis as well as unsuspected cranial nerve palsies. Changes in the extent and pattern of enhancement may well prove useful in monitoring the progress of the disease and in assessing the effects of treatment.
